10 Value stocks with Strong Moats | Moats and Risks of Divis Labs
18.6 هزار بار بازدید -
پارسال
-
Promo Code: YADNYA (30% Discount
Promo Code: YADNYA (30% Discount on Model Portfolios)
The last 12-18 months have witnessed a time based and price based correction in the stock market. Some stocks have seen a big correction from their all time highs and are presenting a good opportunity to understand and analyse from the point of view of owning them for the long term. In this series we analyse some of the value stocks which have strong moats and try to determine if they truly present a good opportunity. In this series, we would also talk about the risks of the business along with the moats.
00:00 Introduction
01:58 DIVIS LABORATORIES – BUSINESS MODEL
03:37 Contribution by Segments
04:02 Moat No. 1 – Clear Focus!
06:34 Moat No. 3 – Market leadership in key APIs in the global pharma space
07:35 Drugs going off-patent in future
08:02 Moat No. 2 – Backward integration
09:43 Moat No. 4 – Working with Big Pharma companies
10:56 Moat No. 5 – Clear Growth Drivers
12:05 Risk No. 1 – Segment Mix
13:33 Risk No. 2 – Although long term growth has been robust, both Generic API and Custom Synthesis
15:32 Risk No. 3 – Margins have decreased sharply in FY23
16:58 Risk No. 4 – Export Dependence
Yadnya's Model Portfolios: https://investyadnya.in/model-portfolios
Yadnya's Stock-O-Meter Plus Subscription : https://investyadnya.in/stock-o-meter
Yadnya's Portfolio Tracker : https://investyadnya.in/portfolio-tra...
Yadnya Shorts Youtube Channel Link : @investyadnyashorts3050
LEGAL DISCLAIMER:
Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.
DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:
Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.
The last 12-18 months have witnessed a time based and price based correction in the stock market. Some stocks have seen a big correction from their all time highs and are presenting a good opportunity to understand and analyse from the point of view of owning them for the long term. In this series we analyse some of the value stocks which have strong moats and try to determine if they truly present a good opportunity. In this series, we would also talk about the risks of the business along with the moats.
00:00 Introduction
01:58 DIVIS LABORATORIES – BUSINESS MODEL
03:37 Contribution by Segments
04:02 Moat No. 1 – Clear Focus!
06:34 Moat No. 3 – Market leadership in key APIs in the global pharma space
07:35 Drugs going off-patent in future
08:02 Moat No. 2 – Backward integration
09:43 Moat No. 4 – Working with Big Pharma companies
10:56 Moat No. 5 – Clear Growth Drivers
12:05 Risk No. 1 – Segment Mix
13:33 Risk No. 2 – Although long term growth has been robust, both Generic API and Custom Synthesis
15:32 Risk No. 3 – Margins have decreased sharply in FY23
16:58 Risk No. 4 – Export Dependence
Yadnya's Model Portfolios: https://investyadnya.in/model-portfolios
Yadnya's Stock-O-Meter Plus Subscription : https://investyadnya.in/stock-o-meter
Yadnya's Portfolio Tracker : https://investyadnya.in/portfolio-tra...
Yadnya Shorts Youtube Channel Link : @investyadnyashorts3050
LEGAL DISCLAIMER:
Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.
DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:
Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.
پارسال
در تاریخ 1402/02/19 منتشر شده
است.
18,651
بـار بازدید شده